Jianqiang Wu | Melanoma | Best Researcher Award

Posted on by Pencis

Mr. Jianqiang Wu | Melanoma | Best Researcher Award

Guangzhou Medical University | China

AUTHOR PROFILE

ORCID ID

🏥MR. JIANQIANG WU: ACADEMIC AND PROFESSIONAL PROFILE

🎓EARLY ACADEMIC PURSUITS

Mr. Jianqiang Wu pursued his medical education with a focus on dermatology, establishing a strong foundation in medical sciences. His early academic years were marked by rigorous training, research involvement, and a keen interest in skin-related disorders, particularly melanoma.

🩺PROFESSIONAL ENDEAVORS

Currently serving at the Department of Dermatology, the Affiliated Panyu Central Hospital, Guangzhou Medical University, China, Mr. Wu has been an integral part of the institution’s dermatological research and clinical services. His dedication to patient care and medical research has significantly contributed to advancements in dermatology.

🔬CONTRIBUTIONS AND RESEARCH FOCUS

Mr. Wu has dedicated a substantial part of his career to the study and treatment of melanoma, a serious form of skin cancer. His research focuses on early diagnosis, innovative treatments, and improving therapeutic outcomes for melanoma patients. He has played a pivotal role in developing targeted therapies and exploring the genetic and molecular mechanisms underlying melanoma progression.

🌍IMPACT AND INFLUENCE

Through his research and clinical practice, Mr. Wu has influenced the field of dermatology, particularly in the early detection and treatment of melanoma. His work has led to improved diagnostic techniques and treatment protocols, benefiting patients in China and beyond. His contributions to medical education have also guided the next generation of dermatologists.

📚ACADEMIC CITATIONS

Mr. Wu’s research findings have been widely cited in peer-reviewed journals, reflecting their significance in the scientific community. His publications contribute to a growing body of knowledge in dermatology, particularly in melanoma treatment strategies.

🏆LEGACY AND FUTURE CONTRIBUTIONS

With a strong track record in clinical and academic dermatology, Mr. Wu’s legacy is marked by his commitment to advancing melanoma research. His future endeavors may include further innovation in personalized medicine, novel therapeutic approaches, and international collaborations to combat skin cancer more effectively.

💊OTHER IMPORTANT TOPICS

  • Collaborations: Engages in interdisciplinary collaborations with oncologists, geneticists, and immunologists to enhance melanoma treatment.
  • Mentorship: Actively mentors young dermatologists, contributing to the academic and professional growth of upcoming medical professionals.
  • Public Health Initiatives: Involved in skin cancer awareness campaigns, promoting early detection and prevention measures in the community.
  • Technological Integration: Advocates for the use of AI and advanced imaging technologies in dermatological diagnostics.

🧬CONCLUSION

Mr. Jianqiang Wu has made remarkable contributions to the field of dermatology, particularly in melanoma research and treatment. His dedication to patient care, innovative research, and academic mentorship ensures that his impact will be felt for years to come. As he continues to push the boundaries of dermatological science, his work stands as a testament to his unwavering commitment to medical advancement and improved patient outcomes.

 

📊🔬NOTABLE PUBLICATION:
    1. Title: CRIP1 inhibits cutaneous melanoma progression through TFAM-mediated mitochondrial biogenesis
      Authors: Jianqiang Wu, Lixia Chen, Peijun Wen.
      Journal: Scientific Reports
      Year: 2025

Mr. Tianhao Zou | Cancer Immunotherapy | Best Researcher Award

Posted on by Pencis

Mr. Tianhao Zou | Cancer Immunotherapy | Best Researcher Award

Tongji Medical College Huazhong University of Science and Technology | China

Author Profile

Scopus

🌟Dr. Tianhao Zou: A Rising Star in Hepatobiliary Oncology 🌟

Full Name: Tianhao Zou
Gender: Male
Designation: Resident Physician
Department: Department of Hepatobiliary Surgery, Center for Liver Transplantation
Institution/Organization: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
Qualification: Doctor
Area of Specialization: Hepatobiliary Oncology and Cancer
Sub Division: Oncology Therapeutics and Novel Approaches
DOB: September 10, 1997
DOJ: July 01, 2021
Total Experience: Doctor for 1 year, Master for 3 years, Bachelor for 5 years
Mobile Number: +86 18162279089
Email: zoutianhao@126.co

📚 Education:

  • 2015-2020: Bachelor of Clinical Medicine, School of Medicine of Nanchang University.
  • 2020-2023: Master of Surgery, Tongji Medical College, Huazhong University of Science and Technology.
  • 2023-present: Doctor of Surgery, Tongji Medical College, Huazhong University of Science and Technology.

🔬 Experience:

  • July 2021 to present: Resident Physician, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology.

🏅 Research, Innovations, and Extensions:

  • No. of Research Projects Completed and Ongoing: 6
  • Citation Index: 61
  • Consultancy and Industry Sponsored Projects: 0
  • Books Published with ISBN: 0
  • Total Cost of Projects: $414,000 USD
  • Patents Published and Under Process: 5
  • Journals Published in SCI and SCIE Index: 12
  • Editorial Appointments in Journals/Conferences: 2
  • Journals Published in Scopus, Web of Science, and PubMed Index: 13
  • Countries Visited for Research Activities: 1
  • Journals Published in Other Index: 4
  • Research Scholars Graduated: 0
  • Conference Presentations: 0
  • Research Scholars Ongoing: 0
  • Cumulative Impact Factor (Last 3 Years): 55
  • Invited Speaker/Resource Person: 1
  • H-index: 5
  • Research Conferences/Workshops Organized: 0
  • Collaborative Activities for Research: 0
  • Awards and Recognition Received: 1
  • Functional MoUs with Other Universities/Industries/Corporates: 0
  • Membership in Professional Bodies: 10

🌟 Areas of Research:

  • Oncology Therapeutics and Novel Approaches

Contributions to Research & Development, Innovations, and Extension Activities:

Dr. Tianhao Zou has made substantial contributions to the field of tumor research, particularly focusing on hepatobiliary malignancies. His active participation in research projects has significantly advanced the understanding of tumor biology, therapeutic interventions, and patient care outcomes. By collaborating with interdisciplinary teams, Dr. Zou has identified novel biomarkers, therapeutic targets, and treatment modalities aimed at improving patient outcomes and quality of life.

In his innovative efforts, Dr. Zou has played a pivotal role in translating research findings into clinical practice. His collaborations with industry stakeholders, academic institutions, and healthcare providers have facilitated the development and implementation of cutting-edge technologies and treatment approaches in oncology.

Beyond his research endeavors, Dr. Zou is committed to extension activities that promote cancer prevention, early detection, and treatment within the community. Through educational workshops, public seminars, and outreach programs, he empowers patients, caregivers, and healthcare professionals with essential information and resources to combat cancer effectively. Dr. Zou’s dedication to advancing cancer research, innovation, and community outreach underscores his commitment to making a meaningful impact in the fight against cancer.

🔗 Proof Links:

Institute ID: D202382031
Certificate (Education Proof of Last Degree): 1048732023102672
Passport/Govt. ID (Age Proof): 360425199709100212

🎖️Suitable Award Categories:

  • Distinguished Scientist Award
  • Young Scientist Award
  • Lifetime Achievement Award
  • Outstanding Scientist Award
  • Women Research Award
  • Best Researcher Award
  • Best Innovation Award
  • Best Faculty Award
  • Best Research Scholar Award
  • Excellence in Innovation
  • Excellence in Research
  • Excellence Award (Any Scientific Field)
  • Best Research/Innovation Extension Activity

📜✍️Declaration:

I authenticate that to the best of my knowledge, the information given in this form is correct and complete. At any time I am found to have concealed any material information, my application shall be liable to be summarily terminated without notice. I have read the terms and conditions and other policies of the International Research Awards and agree to stand by the same. I agree to Pencis to process the data submitted in this application form, or any other data that the Foundation may obtain from me for any purposes connected with Pencis for any other legitimate reason.

📊🔬Notable Publication:

 

 

  • Title: Cell therapy for neuropathic pain
    • Authors: Yin, Q.; Zou, T.; Sun, S.; Yang, D.
    • Journal: Frontiers in Molecular Neuroscience
    • Volume: 16
    • Pages: 1119223
    • Year: 2023